prof. Dr. Bengt FADEEL
H-Index: 75

prof. Dr. Bengt FADEEL

Institute of Environmental Medicine at Karolinska Institutet, Stockholm, Sweden, EU


Position: Professor of Medical Inflammation Research and Vice Chairman of the Institute of Environmental Medicine at Karolinska Institutet, Stockholm, Sweden.

Field of interest: Molecular toxicology: mechanisms of toxicity and implications for human disease; Fundamental mechanisms of inflammation.


At the NANOCON´24 conference Prof. Bengt Fadeel will deliver a plenary lecture on nanotoxicology.


Background and Education:

Prof. Bengt Fadeel obtained his M.D. at Karolinska Institutet in 1997 and his Ph.D. at Karolinska Institutet in 1999. He is a board-certified physician since 2001, and a Full Professor at Karolinska Institutet since 2010. He was the Vice Chairman of the Institute of Environmental Medicine from 2009–2013 and currently serves as Vice Chairman of the Institute of Environmental Medicine since 2023.

He was an Adjunct Professor of Environmental and Occupational Health at the University of Pittsburgh 2011–2016. He was elected as a Fellow of the Academy of Toxicological Sciences (ATS) in 2012. He is Editor-in-Chief of Frontiers in Toxicology and a member of the editorial board of several other journals.

Karolinska Institutet is one of the world’s leading medical universities. The Nobel Assembly at Karolinska Institutet selects the Nobel laureates in Physiology or Medicine. The Institute of Environmental Medicine (IMM) is a department at Karolinska Institutet and a national institute devoted to environmental medicine and health. Today, IMM has about 350 employees and affiliated members.


Research interests:

Research aims of the Division of Molecular Toxicology headed by Prof. Fadeel are to identify and characterize molecular and biochemical processes that are induced by exposure to toxic substances including engineered nanomaterials. The laboratory is also engaged in studies of the molecular mechanisms of inflammation. The nanotoxicological research focuses on the elucidation of mechanisms underlying the toxicity of nanomaterials and other advanced materials with particular focus on hazardous effects on the immune system. Additionally, biomedical applications of nanomaterials are addressed. The latter work is supported through the European Innovation Council (EIC) funded project PERSEUS. The laboratory has also participated in the Graphene Flagship (2013–2023).


Summary of publication activity:

Author/co-author of 302 publications in international peer-reviewed journals with 19.000 citations, and Editor of Adverse Effects of Engineered Nanomaterials: Exposure, Toxicology, and Impact on Human Health (Elsevier) (first edition published in 2012); (ORCID ID ),  H-index: 75 (WoS, January 2024).